Haddadin Yezan Munther

CIK 00017180041 companyISELIN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001718004

Recent Transactions

28 trades

Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2026-06-02$0.83/sh+29,000→ 66,167 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2026-05-26$0.44/sh+34,000→ 37,167 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2025-10-03+95,969→ 95,969 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2025-10-01+286,734→ 286,734 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-03+19,771→ 19,771 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+132,293→ 132,293 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+56,636→ 56,636 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2024-03-28$11.82/sh+1,881.711→ 5,048.711 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-03-07+94,441→ 94,441 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-10-04+358,337→ 358,337 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-03-29+41,065→ 41,065 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-10-07$1.27/sh+3,600→ 63,343 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-10-06$1.29/sh+29,743→ 59,743 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-10-05+71,998→ 71,998 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-03-23+21,878→ 21,878 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-12-02$1.39/sh+10,000→ 30,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-10-05+47,335→ 47,335 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-04-19$1.82/sh+10,000→ 20,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-03-24+20,873→ 20,873 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-05$0.51/sh+160,474→ 160,474 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-01+290,372→ 290,372 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-09-22$0.72/sh+10,000→ 10,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-17+135,000→ 135,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-03-19+15,000→ 15,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-01-02$0.99/sh+5,980→ 5,980 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2019-10-03$0.99/sh+80,176→ 80,176 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2019-10-03+15,000→ 15,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2017-10-31+25,000→ 25,000 total

Companies

Outlook Therapeutics, Inc.
Director
$OTLK

Recent Filings

Address

C/O OUTLOOK THERAPEUTICS, INC. 111 S. WOOD AVE, UNIT #100

ISELIN, NJ, 08830

View on SEC.gov